Clinical Trials at National Hospital Organization Kyushu Medical Center
During the past decade, National Hospital Organization Kyushu Medical Center conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 18 clinical trials were completed, i.e. on
average, 45% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5%
of trials that started reached the finish line.
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2001-07-01
2005-04-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "National Hospital Organization Kyushu Medical Center" #1 sponsor was "Pfizer" with 8 trials, followed by "Eli Lilly and Company" with 5 trials
sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Bayer" with 4 trials sponsored and "Celgene"
with 4 trials sponsored. Other sponsors include 23 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kyushu Medical Center"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at National Hospital Organization Kyushu Medical Center
According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kyushu Medical Center" are
"Rheumatoid Arthritis" (6 trials), "Systemic Lupus Erythematosus" (5 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Lupus Erythematosus, Systemic" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "National Hospital Organization Kyushu Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at National Hospital Organization Kyushu Medical Center
Most popular intervention types in "National Hospital Organization Kyushu Medical Center" are "Drug" (47 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (4 trials), "Baricitinib" (3 trials), "Atezolizumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at National Hospital Organization Kyushu Medical Center
The vast majority of trials in "National Hospital Organization Kyushu Medical Center" are
54 trials for "All" genders.
Clinical Trials Status at National Hospital Organization Kyushu Medical Center
Currently, there are NaN active trials in "National Hospital Organization Kyushu Medical Center".
undefined are not yet recruiting,
10 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 25 completed trials in National Hospital Organization Kyushu Medical Center,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in National Hospital Organization Kyushu Medical Center, 4 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 32 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".